Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder

NCT00397098 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
257
Enrollment
INDUSTRY
Sponsor class

Stopped reprioritization of indications

Conditions

Interventions

Sponsor

Sanofi